Publications by authors named "Gilbert Youssef"

Claim this Profile
N
Neuroimaging endpoints for clinical trials in gliomas: the neuro-oncologist perspective.
Vihang Nakhate, Gilbert Youssef, Aleksandra B Lasica, Patrick Y Wen

Curr Opin Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group.
Philipp Karschnia, Jacob S Young, Maarten M J Wijnenga, Tommaso Sciortino, Nico Teske, Gilbert Youssef

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant Glioma.
Gilbert Youssef, Elisa Aquilanti, Julie J Miller, Zhou Lan, Aleksandra B Lasica

Neuro Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4.
Aleksandra B Lasica, Zhou Lan, Julie J Miller, Albert Jiao, Ian Pan, Gilbert Youssef

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect group.
Nico Teske, Antonio Dono, Jacob S Young, Stephanie T Juenger, Gilbert C Youssef

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Minor Response, Volumetric Assessment and Growth Rate Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO perspective.
Martin J van den Bent, Timothy F Cloughesy, Benjamin M Ellingson, Joshua E Allen, Samuel C Blackman, Gilbert Youssef

Neuro Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study to quantify and describe personal social networks in patients with glioblastoma.
John Y Rhee, Carissa Mastrangelo, Paul J Miller, Gilbert Youssef, Zachary Tentor

Neurooncol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group.
Philipp Karschnia, Jacob S Young, Gilbert C Youssef, Antonio Dono, Levin Häni

Neuro Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.
Raymond Y Huang, Gilbert Youssef, Thomas Nelson, Patrick Y Wen, Peter Forsyth

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
lioma esource utreach ith upport: A program to identify and initiate supportive care interventions for unmet needs among adult lower-grade glioma patients.
Rachel Garcia Fox, Ugonma N Chukwueke, Timothy Sannes, Damien Miran, Daniel Chiu, Gilbert Youssef

Neurooncol Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors.
Hia S Ghosh, Ruchit V Patel, Eleanor Woodward, Noah F Greenwald, Varun M Bhave, Gilbert Youssef

Neuro Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design.
Ethan A Wetzel, Amin I Nohman, Annie L Hsieh, David Reuss, Andreas W Unterberg, Gilbert Youssef

J Neurooncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort.
J Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef, Raymond Huang, Gang Li

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes.
Tyler A Lanman, Gilbert Youssef, Raymond Huang, Rifaquat Rahman, Matthew DeSalvo

Neurooncol Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
Martin J van den Bent, Pim J French, Daniel Brat, Joerg C Tonn, Mehdi Touat, Gilbert Youssef

Neuro Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burnout and career satisfaction in young neuro-oncology investigators: Results of the Society for Neuro-Oncology Young Investigator Survey.
Gilbert Youssef, Alvina Acquaye-Mallory, Elizabeth Vera, Milan G Chheda, Gavin P Dunn

Neurooncol Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.
Mary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, Varun Bhave, Alona Muzikansky, Gilbert Youssef

Clin Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas.
Gilbert Youssef, Patrick Y Wen

Curr Neurol Neurosci Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence.
Sebastian M Christ, Gilbert Youssef, Shyam K Tanguturi, Daniel Cagney, Diana Shi

Clin Transl Radiat Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Patrick Y Wen, Martin van den Bent, Gilbert Youssef, Timothy F Cloughesy, Benjamin M Ellingson

J Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression.
Davy Deng, Lubna Hammoudeh, Gilbert Youssef, Yu-Hui Chen, Kee-Young Shin

Neurooncol Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.
Jamie A Dean, Shyam K Tanguturi, Daniel Cagney, Kee-Young Shin, Gilbert Youssef

Neuro Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.
Benjamin M Ellingson, Patrick Y Wen, Susan M Chang, Martin van den Bent, Michael A Vogelbaum, Gilbert Youssef

Neuro Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.
Gilbert Youssef, Rifaquat Rahman, Camden Bay, Wei Wang, Mary Jane Lim-Fat

J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models.
Meenal Datta, Sampurna Chatterjee, Elizabeth M Perez, Simon Gritsch, Sylvie Roberge, Gilbert Youssef

Proc Natl Acad Sci U S A· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis